Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Sanofi Aventis grooms its ranks for biotech partnering

An Erratum to this article was published on 01 October 2009

This article has been updated

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 08 October 2009

    In the version of this article initially published, the writer incorrectly states that “BiPar was spun out of Genentech to develop small-molecule inhibitors….” The text should have read “BiPpar was set up to develop small-molecule inhibitors….” The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Moran, N. Sanofi Aventis grooms its ranks for biotech partnering. Nat Biotechnol 27, 581–582 (2009).

Download citation

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing